Medline Raises $6.3-B in Year’s Biggest IPO

The biggest IPO of 2025 is getting in just before the finish line.

Medline is valued at $30 billion. (Photo: Medline X) 

Medical supply giant Medline has raised $6.26 billion in its initial public offering, selling just over 216 million shares at $29 apiece.

The public offering price values Medline at more than $50 billion, Myles Udland reported for Yahoo Finance.

Private equity giant Blackstone led a consortium of investors that took a majority stake in Medline in 2021, valuing the company at $30 billion. The deal caps the strongest year for the IPO market since 2021.

Wall Street’s outlook for deals and new issues is even more optimistic heading into 2026.

Reports indicate SpaceX is likely to go public in 2026, after the firm struck a deal allowing insiders to sell shares in Elon Musk’s rocketry and satellite business, valuing the company at roughly $800 billion.

Words

Major artificial intelligence players such as OpenAI and Anthropic are also expected to explore IPOs within the next 18 months, according to The Information.

Database giant Databricks, which raised funds this week at a $134 billion valuation, said it could pursue a public offering as soon as next year.